Akoya Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLUE WATER LIFE SCIENCE ADVISORS, LP | 11/14/2024 | 4.70 M | $12.78 M | 0.00% | 9.49% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.58 M | $4.30 M | 100.00% | 3.19% |
VANGUARD GROUP INC | 11/13/2024 | 1.48 M | $4.04 M | 1.44% | 3.00% |
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 11/14/2024 | 790,000 | $2.15 M | 125.71% | 1.60% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 561,609 | $1.53 M | -0.09% | 1.13% |
STATE STREET CORP | 11/14/2024 | 453,296 | $1.23 M | 4.22% | 0.92% |
PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 376,131 | $1.02 M | 0.16% | 0.76% |
GSA CAPITAL PARTNERS LLP | 11/05/2024 | 310,669 | $845,000 | 87.41% | 0.63% |
SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 271,400 | $738,208 | -7.79% | 0.55% |
PEDDOCK CAPITAL ADVISORS, LLC | 10/08/2024 | 234,720 | $638,438 | -0.09% | 0.47% |
MORGAN STANLEY | 11/14/2024 | 170,411 | $463,518 | 57.52% | 0.34% |
OSTERWEIS CAPITAL MANAGEMENT INC | 11/14/2024 | 126,131 | $343,076 | 0.00% | 0.25% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 105,600 | $287,232 | -41.20% | 0.21% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 63,002 | $171,365 | -64.18% | 0.13% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 56,382 | $153,359 | -16.43% | 0.11% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 52,889 | $143,858 | 296.89% | 0.11% |
CITADEL ADVISORS LLC | 11/14/2024 | 51,798 | $140,891 | 566.47% | 0.10% |
ZWJ INVESTMENT COUNSEL INC | 10/16/2024 | 45,275 | $123,148 | -2.58% | 0.09% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 40,827 | $111,049 | 0.00% | 0.08% |
BARCLAYS PLC | 11/19/2024 | 39,472 | $107,000 | 320.94% | 0.08% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 33,050 | $89,896 | 0.00% | 0.07% |
RHUMBLINE ADVISERS | 11/12/2024 | 30,461 | $82,847 | 6.02% | 0.06% |
JANE STREET GROUP, LLC | 11/15/2024 | 30,421 | $82,745 | -31.96% | 0.06% |
TRANSCEND CAPITAL ADVISORS, LLC | 10/15/2024 | 27,600 | $75,072 | 100.00% | 0.06% |
CITADEL ADVISORS LLC | 11/14/2024 | 24,100 | $65,552 | 265.15% | 0.05% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 20,834 | $56,668 | 0.84% | 0.04% |
HIGHTOWER ADVISORS, LLC | 11/14/2024 | 20,200 | $55,000 | -25.74% | 0.04% |
REGAL INVESTMENT ADVISORS LLC | 11/12/2024 | 17,729 | $48,223 | -5.50% | 0.04% |
XTX TOPCO LTD | 11/14/2024 | 15,380 | $41,834 | -18.98% | 0.03% |
AMERIPRISE FINANCIAL INC | 11/14/2024 | 15,300 | $41,616 | -22.34% | 0.03% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 14,922 | $40,588 | 31.02% | 0.03% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 14,491 | $39,000 | 100.00% | 0.03% |
COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 14,208 | $38,646 | -0.61% | 0.03% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 13,503 | $36,728 | 100.00% | 0.03% |
JPMORGAN CHASE & CO | 12/26/2024 | 12,220 | $33,238 | 2.95% | 0.02% |
NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 11,802 | $32,000 | 0.00% | 0.02% |
TWO SIGMA SECURITIES, LLC | 11/14/2024 | 11,087 | $30,157 | 100.00% | 0.02% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 8,183 | $22,258 | -3.81% | 0.02% |
UBS GROUP AG | 11/14/2024 | 7,044 | $19,160 | -13.70% | 0.01% |
ROYAL BANK OF CANADA | 11/14/2024 | 3,219 | $9,000 | 15.01% | 0.01% |
FMR LLC | 11/13/2024 | 2,831 | $7,700 | 98.39% | 0.01% |
LEGAL & GENERAL GROUP PLC | 11/14/2024 | 2,510 | $6,815 | 0.00% | 0.01% |
GROUP ONE TRADING, L.P. | 11/14/2024 | 2,043 | $5,557 | 0.00% | 0.00% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 11/14/2024 | 1,925 | $5,236 | 0.00% | 0.00% |
SIT INVESTMENT ASSOCIATES INC | 11/13/2024 | 1,854 | $5,000 | 0.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 1,698 | $4,619 | -74.76% | 0.00% |
AMERITAS INVESTMENT PARTNERS, INC. | 11/13/2024 | 1,199 | $3,261 | 0.00% | 0.00% |
RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 568 | $1,545 | 64.16% | 0.00% |
AMALGAMATED BANK | 10/30/2024 | 465 | $1,000 | 0.00% | 0.00% |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/14/2024 | 400 | $1,088 | 0.00% | 0.00% |
Akoya Biosciences, Inc.institutional Ownership - FAQ's
During the previous two years, 64 institutional investors and hedge funds held shares of Akoya Biosciences, Inc.. The most heavily invested institutionals were:
Nelson, Van Denburg & Campbell Wealth Management Group, LLC: 0
Blue Water Life Science Advisors, LP: 4.7 M
BlackRock Funding, Inc. /DE: 1.58 M
VANGUARD GROUP INC: 1.48 M
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE: 790,000
GEODE CAPITAL MANAGEMENT, LLC: 561,609
24.43% of Akoya Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 13.13 M shares in the last 24 months. This purchase volume represents approximately $41.37 M in transactions.